📰 Clinical Development News
Page 54 - Clinical Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Development. Real-time updates on events, politics, business and more.
December 12, 2023
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "FLUMIST QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about FLUMIST QUADRIVALENT for seasonal influenza in the six major markets. A detailed picture of the FLUMIST QUADRIVALENT for seasonal influenza in the 6MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom for the study period 2019 -...
December 12, 2023
– ZUMA-1 Post-Hoc Analysis Shows Five-Year Lymphoma-Related Event-Free Survival in a Substantial Proportion of Patients with Refractory Large B-cell Lymphoma – – Four-Year Follow-up from...
December 12, 2023
Last-line multiple myeloma patients, who have exhauster other treatment options have been responding to oral drug inobrodib in combination with pomalidomide and dexamethasone (pom and dex).
December 12, 2023
Clinical-stage pharma company, PharmaKure which develops precision medicine for Alzheimer’s Disease and other neurological diseases has announced a collaboration agreement with one of the largest comprehensive universities in Malaysia.
December 12, 2023
(BPT) - By Divya Patel, DO, MBA and Director of Clinical Development and Medical Affairs for IPF/ILD, Boehringer IngelheimUpon their return from service and in the decades that follow, veterans can …
December 12, 2023
In CARTITUDE-4, CARVYKTI® demonstrated clinically meaningful improvements in patient-reported outcomes when compared to standard of careThe as-treated population in CARTITUDE-4 demonstrated strong rates of progression-free survival and overall responseLonger-term data from CARTITUDE-2 showed deep and durable respons...
December 12, 2023
The AIDS and Cancer Specimen (ACSR), a biorepository of specimens collected from persons living with HIV (PLWH) has today (December 12) announced it is using software from Proscia that can provide near real-time access to pathology data to investigators around the world.
December 12, 2023
René van der Merwe, MBChB, appointed as Chief Medical Officer Tapan Maniar, Ph.D., joins as Chief Business Officer Company on track to initiate a Phase 2…
December 11, 2023
56% ORR in TKI-naïve patients, including 86% ORR by PPR criteria and 100% ORR in APEX patients treated at 100 mg BID with exposures consistent with go-forward dose Nearly all patients achieved at...